Alternative biomanufacturing routes for natural and synthetic rubber
Quick Facts
Email me updates on this grant
Get notified about:
- Deadline changes
- New FAQs & guidance
- Call reopened
- Q&A webinars
We'll only email you about this specific grant. Unsubscribe anytime. No spam.
Ready to Apply?
Get a personalized assessment of your eligibility and application strategy
See in 5 min if you're eligible for Alternative biomanufacturing routes for natural and synthetic rubber offering max €172.1M funding💰 Funding Details
Funding Description
Call Overview
* Title: *Alternative biomanufacturing routes for natural and synthetic rubber*
* Call ID: HORIZON-JU-CBE-2025-RIA-03
* Type of Action: HORIZON JU Research & Innovation Action (RIA) – Model Grant Agreement: HORIZON-AG
* Opening Date: 03 April 2025
* Deadline: 18 September 2025 – 17:00 (Brussels time)
* Indicative Budget per Grant: up to €172.1 million (JU co-funding, subject to ranking & budget availability)
Strategic Policy Fit
The topic underpins multiple EU flagship policies:
* EU Initiative on Biotechnology & Biomanufacturing
* Bioeconomy Strategy & Action Plan
* Zero-Pollution Ambition (Chemicals Strategy for Sustainability)
* EU Industrial Strategy & raw-material Strategic Autonomy agenda
* Biodiversity Strategy 2030 and Regulation on Deforestation-Free Products (EUDR)
Expected Outcomes
1. Wider availability of sustainable natural and/or bio-based synthetic rubber inside the EU value chain.
2. Competitive, high-performance biomanufacturing routes with superior environmental metrics (LCA, resource efficiency, microplastic prevention).
3. Market-ready elastomers that meet stringent end-use specifications in automotive, construction, industrial, healthcare and consumer sectors.
Scope Highlights
* Identify & optimise rubber-bearing genetic backgrounds (plants, yeasts, microbial hosts).
* Deploy advanced biotechnology / synthetic biology for high isoprenoid or alternative elastomer yield.
* Demonstrate EU/Associated Countries (EU/AC)-based production, extraction & processing at relevant scale.
* Provide rigorous environmental assessments (ILUC, microplastics, water/energy use).
* Ensure complementarity with projects such as *MIDAS* & *NORDIC BIO-RUBBER*.
* Contribute to global policy dialogues (IBF, Global Bioeconomy Summit, etc.).
Funding Rate & Eligibility
* RIA funding rate: 100 % of eligible direct costs + 25 % flat-rate indirect costs.
* Consortium must include ≥ 3 legal entities from ≥ 3 different EU/AC states.
* Entities from non-associated countries may participate with own funding or exceptional EU support (check HE Programme Guide).
* Special attention to financial & operational capacity, exclusion grounds, and security considerations (Annexes B–G HE GA).
---
📊 At a Glance
Get Grant Updates
Get notified about:
- Deadline changes
- New FAQs & guidance
- Call reopened
- Q&A webinars
We'll only email you about this specific grant. Unsubscribe anytime. No spam.
🇪🇺 Strategic Advantages
EU-wide Advantages and Opportunities for Horizon-JU-CBE-2025-RIA-03: Alternative biomanufacturing routes for natural and synthetic rubber
1. Single Market Access
- Immediate entry into a tariff-free market of 450+ million consumers and 23 million SMEs.
- Uniform technical standards (EN, ISO, REACH) enable rapid commercialisation of bio-rubber products for automotive, construction and medical sectors across 27 Member States without country-by-country re-certification.
- Public procurement directives (≈14 % of EU GDP) offer early demand, e.g. green public procurement for sustainable tyres, medical gloves and infrastructure gaskets.
2. Cross-Border Collaboration & Knowledge Exchange
- CBE JU rules require consortia from at least three different countries, encouraging pooling of Europe’s complementary assets (e.g. Belgian synthetic biology SMEs + Spanish natural-rubber agronomists + German tyre OEMs).
- Access to EU infrastructures: ESFRI plant-phenotyping platforms (EMPHASIS), industrial-biotech pilot lines (IBISBA, Bio Base Europe) and the European Biofoundries Alliance.
- Mobility tools (MSCA, Erasmus+, COST Actions) facilitate staff exchange, shortening time-to-market through shared learning.
3. Alignment with Flagship EU Policies
- Direct contribution to the European Green Deal, Circular Economy Action Plan and Fit-for-55 by replacing fossil-derived elastomers and reducing imported, deforestation-linked natural rubber.
- Supports the EU Bioeconomy Strategy, Chemicals Strategy for Sustainability, Industrial Strategy and the Regulation on Deforestation-free Products.
- Reinforces the Strategic Autonomy agenda and the Critical Raw Materials Act by diversifying rubber feedstocks made inside the Union.
4. Regulatory Harmonisation Benefits
- One-stop compliance with REACH, CLP and the forthcoming microplastics restriction instead of 27 separate national regimes.
- EU Taxonomy for Sustainable Activities can label bio-rubber production as taxonomy-aligned, unlocking green finance across all Member States.
- Future-proofing through anticipated EU standards on Sustainable Carbon Cycles and Product Environmental Footprint (PEF).
5. Access to Europe’s Innovation Ecosystem
- Integration with EIT Manufacturing, EIT RawMaterials and EIT Climate-KIC accelerators for piloting and market traction.
- Collaboration with flagship Horizon projects (MIDAS, NORDIC BIO-RUBBER, SUSFERT, BIO-ELECTRO) provides validated datasets, protocols and IP licensing opportunities.
- Clusters such as the Bio-Based Industries Consortium (BIC) and the European Tyre & Rubber Manufacturers Association (ETRMA) offer dissemination channels to 4 000+ companies.
6. Funding Synergies & Leverage
- Blending possibilities with:
• EIC Transition & Accelerator for scale-up capital.
• InvestEU Green Transition window for first-of-a-kind plants.
• ERDF & Just Transition Fund for regional biorefineries in coal-dependent regions (e.g. Silesia, Asturias).
• LIFE programme for demonstrators tackling microplastic release.
- Compatibility with the State-aid framework for Important Projects of Common European Interest (IPCEI) on biomanufacturing could provide further CAPEX support.
7. Scale & Impact Potential
- Union-wide deployment could replace up to 25 % of imported natural rubber (≈250 kt yr⁻¹) by 2035, cutting ≈1.4 Mt CO₂-eq and 200 000 ha deforestation pressure.
- Creates resilient supply chains for strategic sectors (automotive tyres, medical devices) and about 30 000 skilled jobs in rural and industrial regions.
- Facilitates market uptake in 15+ application domains thanks to harmonised CE marking and EU Medical Device Regulation pathways.
8. Global Standard-Setting & Trade Advantages
- Projects can shape ISO/TC 45 and UNECE tyre regulations with EU sustainability criteria, exporting ‘green rubber’ standards globally.
- Strengthens EU trade negotiations (e.g. with ASEAN, Mercosur) by showcasing credible alternatives to deforestation-linked natural rubber.
9. Intellectual Property & Data Assets
- Benefit from the Unitary Patent and the Unified Patent Court for lower IP costs across 17+ Member States.
- Use European data spaces (planned Bioeconomy Data Space) to share genomics and LCA datasets under common governance, ensuring GDPR compliance and FAIR principles.
10. Skills, Social & Regional Cohesion
- Connect to the Pact for Skills for the European bio-based sector and Blueprint curricula, ensuring workforce availability.
- Rural-development alignment with CAP Strategic Plans offers farmers alternative high-value crops (e.g. dandelion, guayule) with low indirect land-use change (ILUC).
- Supports Just Transition goals by re-purposing petrochemical assets into bio-rubber facilities.
11. Actionable Recommendations for Applicants
1. Build a geographically balanced consortium combining:
• Feedstock developers (CZ, RO, EL)
• Industrial biotech & biofoundries (BE, NL, FR)
• Rubber processors & OEMs (DE, IT, ES)
• LCA & social scientists (SE, AT)
2. Map complementarities with ongoing CBE JU projects and plan joint standardisation workshops under CEN.
3. Integrate a policy work package to feed evidence into the EU Critical Raw Materials Board and the microplastics REACH restriction.
4. Anticipate a blended-finance pathway: TRL 5-6 under this RIA → TRL 7-8 under a future CBE JU Innovation Action → commercial first-of-a-kind plant via Innovation Fund/InvestEU.
🏷️ Keywords
Ready to Apply?
Get a personalized assessment of your eligibility and application strategy
See in 5 min if you're eligible for Alternative biomanufacturing routes for natural and synthetic rubber offering max €172.1M funding